p.125 抽出テキスト
528. Capodanno D, Petronio AS, Prendergast B, et al. Standardized definitions of structural deterioration and valve failure in assessing longterm durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2017; 38: 3382- 3390. PMID: 29020344 529. Dvir D, Bourguignon T, Otto CM, et al. VIVID (Valve in Valve International Data) Investigators. Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves. Circulation 2018; 137: 388-399. PMID: 29358344 530. Turina J, Hess O, Sepulcri F, et al. Spontaneous course of aortic valve disease. Eur Heart J 1987; 8: 471-483. PMID: 3609042 531. Pereira JJ, Lauer MS, Bashir M, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol 2002; 39: 1356-1363. PMID: 11955855 532. Shimura T, Yamamoto M, Kano S, et al. OCEAN-TAVI Investigators. Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement. Circulation 2017; 135: 2013-2024. PMID: 28302751 533. Yanagisawa R, Tanaka M, Yashima F, et al. Frequency and Consequences of Cognitive Impairmentin Patients Underwent Transcatheter Aortic Valve Implantation. Am J Cardiol 2018; 122: 844-850. PMID: 30072128 534. Pai RG, Kapoor N, Bansal RC, et al. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg 2006; 82: 2116-2122. PMID: 17126122 535. Pellikka PA, Nishimura RA, Bailey KR, et al. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990; 15: 1012-1017. PMID: 2312954 536. Brown ML, Pellikka PA, Schaff HV, et al. The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis. J Thorac Cardiovasc Surg 2008; 135: 308-315. PMID: 18242258 537. Banovic M, Iung B, Bartunek J, et al. Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial. Am Heart J 2016; 174: 147-153. PMID: 26995381 538. Ledwoch J, Thiele H. Treatment of asymptomatic aortic valve stenosis : Watchful waiting or early intervention? Herz 2017; 42: 528-535. PMID: 28593422 539. Amato MC, Moffa PJ, Werner KE, et al. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart 2001; 86: 381-386. PMID: 11559673 540. Dahl JS, Eleid MF, Michelena HI, et al. Effect of left ventricular ejection fraction on postoperative outcome in patients with severe aortic stenosis undergoing aortic valve replacement. Circ Cardiovasc Imaging 2015; 8: e002917. PMID: 25852129 541. Taniguchi T, Morimoto T, Shiomi H, et al. CURRENT AS Registry Investigators. Prognostic Impact of Left Ventricular Ejection Fraction in Patients With Severe Aortic Stenosis. JACC Cardiovasc Interv 2018; 11: 145-157. PMID: 29289632 542. Tastet L, Tribouilloy C, Maréchaux S, et al. Staging Cardiac Damage in Patients With Asymptomatic Aortic Valve Stenosis. J Am Coll Cardiol 2019; 74: 550-563. PMID: 31345430 543. Kitai T, Honda S, Okada Y, et al. Clinical outcomes in non-surgically managed patients with very severe versus severe aortic stenosis. Heart 2011; 97: 2029-2032. PMID: 21954228 544. Nistri S, Faggiano P, Olivotto I, et al. Hemodynamic progression and outcome of asymptomatic aortic stenosis in primary care. Am J Cardiol 2012; 109: 718-723. PMID: 22154322 545. Bohbot Y, Kowalski C, Rusinaru D, et al. Impact of Mean Transaortic Pressure Gradient on Long-Term Outcome in Patients With Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction. J Am Heart Assoc 2017; 6: e005850. PMID: 28572283 546. Maréchaux S, Ringle A, Rusinaru D, et al. Prognostic Value of Aortic Valve Area by Doppler Echocardiography in Patients With Severe Asymptomatic Aortic Stenosis. J Am Heart Assoc 2016; 5: e003146. PMID: 27143354 547. Pai RG, Varadarajan P, Kapoor N, et al. Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension. Ann Thorac Surg 2007; 84: 80-85. PMID: 17588389 548. Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004; 109: 2302-2308. PMID: 15117847 549. Lancellotti P, Moonen M, Magne J, et al. Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis. Am J Cardiol 2010; 105: 383- 388. PMID: 20102953 550. Nakatsuma K, Taniguchi T, Morimoto T, et al. CURRENT AS Regis- try Investigators. B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis. Heart 2019; 105: 384-390. PMID: 30530820 551. Henri C, Dulgheru R, Magne J, et al. Impact of Serial B-Type Natriuretic Peptide Changes for Predicting Outcome in Asymptomatic Patients With Aortic Stenosis. Can J Cardiol 2016; 32: 183-189. PMID: 26371385 552. Smith WT 4th, Ferguson TB Jr, Ryan T, et al. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. J Am Coll Cardiol 2004; 44: 1241- 1247. PMID: 15364326 553. Dagenais F, Mathieu P, Doyle D, et al. Moderate aortic stenosis in coronary artery bypass grafting patients more than 70 years of age: to replace or not to replace? Ann Thorac Surg 2010; 90: 1495-1500. PMID: 20971247 554. Rieck ÅE, Cramariuc D, Boman K, et al. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events. Hypertension 2012; 60: 90-97. PMID: 22647889 555. Bhattacharyya S, Hayward C, Pepper J, et al. Risk stratification in asymptomatic severe aortic stenosis: a critical appraisal. Eur Heart J 2012; 33: 2377-2387. PMID: 22766580 556. Zilberszac R, Gabriel H, Schemper M, et al. Asymptomatic Severe Aortic Stenosis in the Elderly. JACC Cardiovasc Imaging 2017; 10: 43-50. PMID: 27639763 557. Izumi C. Asymptomatic severe aortic stenosis: challenges in diagnosis and management. Heart 2016; 102: 1168-1176. PMID: 27091844 558. Bohbot Y, Rusinaru D, Delpierre Q, et al. Risk Stratification of Severe Aortic Stenosis With Preserved Left Ventricular Ejection Fraction Using Peak Aortic Jet Velocity: An Outcome Study. Circ Cardiovasc Imaging 2017; 10: e006760. PMID: 29021260 559. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004; 43: 405-409. PMID: 15013122 560. Behm CZ, Nath J, Foster E. Clinical correlates and mortality of hemodynamically significant tricuspid regurgitation. J Heart Valve Dis 2004; 13: 784-789. PMID: 15473480 561. Topilsky Y, Nkomo VT, Vatury O, et al. Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging 2014; 7: 1185- 1194. PMID: 25440592 562. Takahashi Y, Izumi C, Miyake M, et al. Actual management and prognosis of severe isolated tricuspid regurgitation associated with atrial fibrillation without structural heart disease. Int J Cardiol 2017; 243: 251-257. PMID: 28536002 563. Lee JW, Song JM, Park JP, et al. Long-term prognosis of isolated significant tricuspid regurgitation. Circ J 2010; 74: 375-380. PMID: 20009355 564. Topilsky Y, Khanna A, Le Tourneau T, et al. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ Cardiovasc Imaging 2012; 5: 314-323. PMID: 22447806 565. Utsunomiya H, Itabashi Y, Mihara H, et al. Functional Tricuspid Regurgitation Caused by Chronic Atrial Fibrillation: A Real-Time 3-Dimensional Transesophageal Echocardiography Study. Circ Cardiovasc Imaging 2017; 10: e004897. PMID: 28073806 566. Topilsky Y, Maltais S, Medina Inojosa J, et al. Burden of Tricuspid Regurgitation in Patients Diagnosed in the Community Setting. JACC Cardiovasc Imaging 2019; 12: 433-442. PMID: 30121261 567. Najib MQ, Vinales KL, Vittala SS, et al. Predictors for the development of severe tricuspid regurgitation with anatomically normal valve in patients with atrial fibrillation. Echocardiography 2012; 29: 140- 146. PMID: 22067002 568. Yamasaki N, Kondo F, Kubo T, et al. Severe tricuspid regurgitation in the aged: atrial remodeling associated with long-standing atrial fibrillation. J Cardiol 2006; 48: 315-323. PMID: 17243626 569. Zhou X, Otsuji Y, Yoshifuku S, et al. Impact of atrial fibrillation on tricuspid and mitral annular dilatation and valvular regurgitation. Circ J 2002; 66: 913-916. PMID: 12381084 570. Izumi C, Iga K, Konishi T. Progression of isolated tricuspid regurgitation late after mitral valve surgery for rheumatic mitral valve disease. J Heart Valve Dis 2002; 11: 353-356. PMID: 12056726 571. Matsuyama K, Matsumoto M, Sugita T, et al. Predictors of residual tricuspid regurgitation after mitral valve surgery. Ann Thorac Surg 2003; 75: 1826-1828. PMID: 12822623 572. Kwak JJ, Kim YJ, Kim MK, et al. Development of tricuspid regurgi- tation late after left-sided valve surgery: a single-center experience with long-term echocardiographic examinations. Am Heart J 2008;